Pharmacogenetics of interaction between depot medroxyprogesterone acetate and efavirenz, rifampicin, and isoniazid during treatment of HIV and tuberculosis

AIDS Clinical Trials Group A5338 Study Team

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Pharmacogenetics of interaction between depot medroxyprogesterone acetate and efavirenz, rifampicin, and isoniazid during treatment of HIV and tuberculosis'. Together they form a unique fingerprint.

Medicine & Life Sciences